Brief: Qlife Enters LoI With Hipro Biotechnology For Reverse Takeover

Qlife Holding AB

05/06/2025 07:07

June 5 (Reuters) - Qlife Holding AB QLIFE.ST:

QLIFE ENTERS LETTER OF INTENT WITH HIPRO BIOTECHNOLOGY CO., LTD. TO JOIN FORCES THROUGH A REVERSE TAKEOVER

WILL ACQUIRE HIPRO AND ISSUE NEW SHARES TO HIPRO'S SHAREHOLDERS

HIPRO'S SHAREHOLDERS WILL HOLD APPROXIMATELY 83.3 PERCENT OF OUTSTANDING SHARES IN QLIFE AFTER TRANSACTION

PURCHASE PRICE FOR HIPRO IS BASED ON A SHARE VALUE OF USD 75 MILLION

PAYMENT WILL BE MADE IN FORM OF ISSUED PROMISSORY NOTES THAT ARE SET OFF AGAINST NEWLY ISSUED SHARES IN QLIFE

AIM IS TO COMPLETE TRANSACTION DURING Q4 OF 2025

PLANS NAME CHANGE AS PART OF DEAL

Source text: ID:nWkr8g3MN9

Further company coverage: QLIFE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))